Cannon Global Investment Management, LLC Royalty Pharma PLC Transaction History
Cannon Global Investment Management, LLC
- $49.7 Million
- Q1 2025
A detailed history of Cannon Global Investment Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cannon Global Investment Management, LLC holds 28,500 shares of RPRX stock, worth $1.02 Million. This represents 1.78% of its overall portfolio holdings.
Number of Shares
28,500
Previous 30,500
6.56%
Holding current value
$1.02 Million
Previous $778,000
14.01%
% of portfolio
1.78%
Previous 1.9%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.47 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$826 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$481 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$436 Million0.52% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...